SequelSEC

HeartSciences Inc. HSCS

Finance Services · CIK 0001468492 · Fiscal year ends 0430 · Bank

AnnualQuarterlyTTM
Revenue
$2.10K
Fiscal year ended 2026-07-31
Net income
-$3.17M
Fiscal year ended 2026-07-31
Total assets
$3.74M
Fiscal year ended 2026-07-31

Valuation, from the filing

Public float$10.40MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-10-31
Float per share$2.67Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2408.0×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity46.0×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-10-31, not today, and each multiple below it uses the figures for the fiscal year ending 2026-04-30 — the year that filing covered.

How this compares in its industry

Percentile among the Finance Services filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
FCF margin-172036.6%0th
R&D / revenue65733.1%100th
SBC / revenue30386.3%99th
Operating margin-194787.4%1th
Net margin-211666.5%2th
CapEx / revenue82.3%85th
Current ratio0.53x22th
Revenue YoY growth-0.7%34th
Gross margin59.1%62th

HeartSciences Inc. (HSCS) reported revenue of $2.10K and net income of -$3.17M for the fiscal year ended 2026-07-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from HeartSciences Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Finance Services.

Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.

Income

HeartSciences Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-312026-04-302026-01-312025-10-312025-07-312025-04-302025-01-312024-04-302024-01-312023-10-31
Revenue$2.10K$0$0$2.42K$1.90K$4.35K$0$0$14.70K$3.90K
Cost of revenue$760$0$0$1.01K$760$1.88K$0$0$4.56K$1.52K
Gross profit$1.34K$0$0$1.41K$1.14K$2.47K$0$0$10.14K$2.38K
Operating income-$2.94M-$2.54M-$1.93M-$2.07M-$1.87M-$1.92M-$2.37M-$1.88M-$1.53M-$1.57M
Net income-$3.17M-$2.75M-$1.99M-$2.35M-$2.05M-$2.09M-$2.54M-$1.85M-$1.64M-$1.75M
Research & development$906.63K$476.20K$638.58K$727.03K$997.21K$929.09K$1.03M$1.05M$509.51K$757.30K
Weighted-average diluted sharesUnavailableUnavailableUnavailableshares 2.78Mshares 1.30MUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPSUnavailableUnavailableUnavailable$-0.85$-1.58Unavailable$-2.57Unavailable$-3.01$-15.92
Selling, general & administrative$2.03M$2.06M$1.29M$1.35M$878.05K$993.78K$1.34M$833.68K$1.03M$815.02K
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

HeartSciences Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-312026-04-302026-01-312025-10-312025-07-312025-04-302025-01-312024-04-302024-01-312023-10-31
Cash & equivalents$29.91K$1.66M$3.40M$1.95M$2.79M$1.10M$2.60M$5.81M$7.08M$100.14K
Total assets$3.74M$5.26M$7.55M$6.00M$6.44M$4.22M$5.70M$9.50M$10.80M$2.37M
Current assets$811.77K$2.58M$5.10M$3.79M$4.42M$2.17M$3.63M$7.35M$8.69M$1.81M
Total liabilities$5.77M$5.04M$4.90M$1.81M$3.30M$4.02M$3.92M$2.19M$2.17M$4.02M
Current liabilities$5.63M$4.86M$4.27M$1.57M$3.01M$3.70M$3.57M$1.75M$1.71M$3.53M
Total equity incl. NCI-$2.03M$226.06K$2.65M$4.18M$3.14M$205.17K$1.79M$7.32M$8.63M-$1.65M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$402.99K$655.63K$657.28K$657.28K$649.51K$650.27K$652.15K$629.18K$670.28K$674.84K
Accounts receivableUnavailableUnavailable$0UnavailableUnavailable$4.35KUnavailableUnavailable$14.70K$3.90K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$1.02M$318.33K$410.73K$317.39K$283.22K$318.66K$405.08K$448.18K$415.08K$1.09M

Cash flow

HeartSciences Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-312026-04-302026-01-312025-10-312025-07-312025-04-302025-01-312024-04-302024-01-312023-10-31
Operating cash flow-$1.32M-$1.68M-$1.46M-$2.33M-$1.95M-$1.59MUnavailable-$1.58M-$2.10MUnavailable
Capital expendituresUnavailable$0-$9.48KUnavailableUnavailable$0Unavailable$48.80K$8.79KUnavailable
Investing cash flow-$280.11K$0-$27.87K-$15.77K-$814-$7.81KUnavailable-$69.23K-$49.18KUnavailable
Financing cash flow-$27.94K-$63.67K$2.94M$1.51M$3.65M$100.03KUnavailable$377.14K$9.13MUnavailable
Net change in cash-$1.63M-$1.74M$1.45M-$841.13K$1.69M-$1.50MUnavailable-$1.27M$6.98MUnavailable
Stock-based compensation$738.89K$324.84K$376.10K$436.88K$174.56K$95.94KUnavailable$78.45K$96.09KUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

HeartSciences Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-312026-04-302026-01-312025-10-312025-07-312025-04-302025-01-312024-04-302024-01-312023-10-31
Free cash flowUnavailable-$1.68MUnavailableUnavailableUnavailable-$1.59MUnavailable-$1.63M-$2.11MUnavailable
Gross margin63.8%UnavailableUnavailable58.3%60.0%56.8%UnavailableUnavailable69.0%61.0%
Operating margin-139956.7%UnavailableUnavailable-85713.2%-98637.8%-44147.1%UnavailableUnavailable-10376.7%-40254.9%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailable-36566.4%UnavailableUnavailable-14352.1%Unavailable
SBC / revenue35185.2%UnavailableUnavailable18060.5%9187.3%2205.6%UnavailableUnavailable653.7%Unavailable
Current ratio0.14x0.53x1.19x2.42x1.47x0.59x1.02x4.20x5.09x0.51x
Revenue YoY growth10.5%-100.0%UnavailableUnavailableUnavailableUnavailable-100.0%Unavailable653.8%Unavailable
Net margin-151064.0%UnavailableUnavailable-97179.4%-108157.6%-48145.5%UnavailableUnavailable-11182.4%-44830.2%
R&D / revenue43172.8%UnavailableUnavailable30054.8%52484.5%21358.4%UnavailableUnavailable3466.0%19418.0%
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailable0.0%UnavailableUnavailable59.8%Unavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HSCS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-09-14View SEC filing
10-K · Filed 2026-07-23View SEC filing
10-Q · Filed 2026-03-16View SEC filing
10-Q · Filed 2025-12-15View SEC filing
10-Q · Filed 2025-09-11View SEC filing
10-K · Filed 2025-07-24View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.